Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction
Open Access
- 18 October 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 1013740
Abstract
Cardiovascular diseases are the leading cause of global mortality, in which myocardial infarction accounts for 46% of total deaths. Although good progress has been achieved in medication and interventional techniques, a proven method to repair the damaged myocardium has not yet been determined. Stem cell therapy for damaged myocardial repair has evolved into a promising treatment for ischemic heart disease. However, low retention and poor survival of the injected stem cells are the major obstacles to achieving the intended therapeutic effects. Chinese botanical and other natural drug substances are a rich source of effective treatment for various diseases. As such, numerous studies have revealed the role of Chinese medicine in stem cell therapy for myocardial infarction treatment, including promoting proliferation, survival, migration, angiogenesis, and differentiation of stem cells. Here, we discuss the potential and limitations of stem cell therapy, as well as the regulatory mechanism of Chinese medicines underlying stem cell therapy. We focus on the evidence from pre-clinical trials and clinical practices, and based on traditional Chinese medicine theories, we further summarize the mechanisms of Chinese medicine treatment in stem cell therapy by the commonly used prescriptions. Despite the pre-clinical evidence showing that traditional Chinese medicine is helpful in stem cell therapy, there are still some limitations of traditional Chinese medicine therapy. We also systematically assess the detailed experimental design and reliability of included pharmacological research in our review. Strictly controlled animal models with multi-perspective pharmacokinetic profiles and high-grade clinical evidence with multi-disciplinary efforts are highly demanded in the future.Keywords
Funding Information
- National Natural Science Foundation of China (82174120 81970991)
- Natural Science Foundation of Shanghai Municipality (21ZR1463100)
This publication has 137 references indexed in Scilit:
- Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4Protoplasma, 2012
- Chemical Components in Extracts from Plastrum Testudinis with Proliferation‐Promoting Effects on Rat Mesenchymal Stem CellsChemical Biology & Drug Design, 2012
- A natural compound induced cardiogenic differentiation of endogenous MSCs for repair of infarcted heartDifferentiation, 2012
- Hexadecanoic Acid from Buzhong Yiqi Decoction Induced Proliferation of Bone Marrow Mesenchymal Stem CellsJournal of Medicinal Food, 2010
- The effect of Xuefu Zhuyu Decoction (血府逐瘀汤) on in vitro endothelial progenitor cell tube formationChinese Journal of Integrative Medicine, 2010
- Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculationEuropean Heart Journal, 2009
- Ethical Issues in Stem Cell ResearchEndocrine Reviews, 2009
- A Plant-Derived Remedy for Repair of Infarcted HeartPLOS ONE, 2009
- Genetic Enhancement of Stem Cell Engraftment, Survival, and EfficacyCirculation Research, 2008
- Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-upAmerican Heart Journal, 2004